Environmental stress factors, such as heat, may induce multidrug resistance gene (mdr1) expression, which could result in the disadvantageous multidrug resistance (MDR) phenotype. To evaluate this possibility in a clinical situation, we investigated mdr1 gene expression in patients with locally adva
Biphasic materials for bone grafting and hyperthermia treatment of cancer
✍ Scribed by D. Arcos; R. P. del Real; M. Vallet-Regí
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 486 KB
- Volume
- 65A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Three biphasic materials have been synthesized from a magnetic glass–ceramic (Si‐Ca‐Fe) and a bioactive sol–gel glass (Si‐P‐Ca). The ratios of glass–ceramic:sol–gel glass used in this work were 1:1, 2:1, and 5:1. These materials show bioactive and magnetic properties and can be used as thermoseeds for hyperthermia treatment of bone tumors. The sol–gel glass content affects the textural properties of the glass–ceramic, giving rise to porosity, which plays a fundamental role in the formation of an apatite‐like layer on the surface. On the other hand, as the sol–gel glass content increases, the magnetic properties change due to the diffusion of Fe ions to the glassy phases of the biphasic materials. The biphasic nature of these materials allows the changing of both properties, depending on the requirements of the patient. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 65A: 71–78, 2003
📜 SIMILAR VOLUMES
Several reports have shown a prolonged survival after surgical treatment of pulmonary metastases from soft tissue sarcomas. However, it is still unclear which prognostic factors predict a favorable outcome. Series are not comparable and the data are conflicting. Therefore, a multi-institutional stud
## Abstract The pliability of cancer cells to mutate into several different phenotypes in an attempt to find one that will survive and colonize at the metastatic site is a tremendous “hurdle” to overcome in designing novel cancer therapeutics. New targets of therapy are essential if we are to effec
## BACKGROUND. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity